HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruth Lupu Selected Research

Integrin alpha Chains

11/2007Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
5/2005AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruth Lupu Research Topics

Disease

58Neoplasms (Cancer)
11/2022 - 08/2002
53Breast Neoplasms (Breast Cancer)
11/2022 - 01/2002
11Neoplasm Metastasis (Metastasis)
01/2022 - 08/2002
6Carcinogenesis
01/2017 - 11/2002
5Carcinoma (Carcinomatosis)
01/2017 - 11/2002
4Adenocarcinoma
11/2012 - 06/2004
3Hypoxia (Hypoxemia)
07/2006 - 01/2005
2Disease Progression
06/2017 - 01/2016
2Ovarian Neoplasms (Ovarian Cancer)
07/2009 - 11/2005
2Endometrial Neoplasms (Endometrial Cancer)
09/2006 - 06/2004
2Hypersensitivity (Allergy)
05/2005 - 01/2005
2Obesity
03/2005 - 07/2004

Drug/Important Bio-Agent (IBA)

36Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2022 - 03/2004
21EnzymesIBA
10/2021 - 03/2004
19Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 03/2004
16Neuregulin-1 (Neuregulin 1)IBA
01/2022 - 08/2002
14histidine-rich proteinsIBA
01/2022 - 08/2002
14Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2002
9Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 01/2003
9Estrogen ReceptorsIBA
03/2021 - 01/2002
8Estrogens (Estrogen)FDA Link
03/2021 - 01/2002
7Hormones (Hormone)IBA
01/2022 - 06/2005
7LigandsIBA
01/2022 - 08/2006
6Trastuzumab (Herceptin)FDA Link
07/2009 - 06/2004
6Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2006 - 03/2004
5IntegrinsIBA
11/2022 - 01/2005
5TamoxifenFDA LinkGeneric
03/2021 - 05/2004
5Paclitaxel (Taxol)FDA LinkGeneric
06/2017 - 01/2005
5Messenger RNA (mRNA)IBA
07/2012 - 01/2002
4Biological ProductsIBA
01/2022 - 01/2005
4LipidsIBA
01/2022 - 01/2005
4Phenobarbital (Luminal)FDA Link
01/2022 - 09/2013
4Pharmaceutical PreparationsIBA
01/2018 - 05/2005
4Transcription Factors (Transcription Factor)IBA
01/2017 - 03/2004
4Antineoplastic Agents (Antineoplastics)IBA
12/2006 - 03/2004
4CeruleninIBA
12/2006 - 03/2004
4Malonyl Coenzyme A (Malonyl CoA)IBA
12/2006 - 06/2004
4Mitogen-Activated Protein KinasesIBA
10/2006 - 06/2004
3Estradiol (Delestrogen)FDA LinkGeneric
03/2021 - 06/2004
3Fulvestrant (Faslodex)FDA Link
10/2020 - 05/2004
3Olive OilIBA
01/2018 - 10/2006
3Oncogene Proteins (Oncogene Protein)IBA
07/2017 - 06/2004
3Phosphotransferases (Kinase)IBA
01/2017 - 08/2006
3DNA (Deoxyribonucleic Acid)IBA
11/2015 - 01/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014 - 11/2002
3Integrin beta3 (GPIIIa)IBA
11/2007 - 05/2005
3Oleic Acid (Oleate)IBA
12/2006 - 10/2006
3MycotoxinsIBA
12/2006 - 06/2004
3Monounsaturated Fatty AcidsIBA
12/2006 - 10/2006
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2006 - 06/2004
3gamma-Linolenic AcidIBA
01/2005 - 05/2004
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2014
2Cadherins (E-Cadherin)IBA
01/2022 - 11/2012
2NADP (NADPH)IBA
10/2021 - 12/2006
2Progesterone Receptors (Progesterone Receptor)IBA
12/2020 - 06/2005
2CytokinesIBA
10/2020 - 04/2005
2Indicators and Reagents (Reagents)IBA
07/2017 - 06/2015
2Monoclonal AntibodiesIBA
05/2017 - 06/2015
2TeaIBA
01/2017 - 12/2006
2PolyphenolsIBA
01/2017 - 12/2006
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2015 - 01/2005
2Plasminogen Activators (Plasminogen Activator)IBA
11/2012 - 08/2002
2Zoledronic Acid (Zometa)FDA Link
05/2011 - 11/2009
2Complementary DNA (cDNA)IBA
11/2009 - 05/2005
2Peptide Hydrolases (Proteases)FDA Link
09/2008 - 08/2002
2Integrin alpha ChainsIBA
11/2007 - 05/2005
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2007 - 08/2002
2Detergents (Detergent)IBA
12/2006 - 01/2005
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2006 - 01/2005
2AntigensIBA
12/2006 - 05/2005
2Cytostatic AgentsIBA
12/2006 - 03/2004
2Acetyl Coenzyme A (Acetyl-CoA)IBA
12/2006 - 01/2005
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
12/2006 - 01/2005
2Orlistat (Xenical)FDA Link
12/2006 - 03/2005
2alpha-Linolenic Acid (Linolenic Acid)IBA
11/2006 - 03/2004
2Docosahexaenoic AcidsIBA
11/2006 - 03/2004
2SteroidsIBA
06/2005 - 06/2004
2OligonucleotidesIBA
05/2005 - 01/2005
2Double-Stranded RNA (RNA, Double Stranded)IBA
05/2005 - 01/2005
2Taxoids (Taxanes)IBA
05/2005 - 03/2004
2Epidermal Growth Factor (EGF)IBA
03/2005 - 01/2005
2U 0126 (UO 126)IBA
01/2005 - 06/2004
2Growth Factor ReceptorsIBA
01/2005 - 01/2005
2Drug CombinationsIBA
08/2004 - 06/2004
2Docetaxel (Taxotere)FDA Link
06/2004 - 03/2004
2Linoleic Acid (Linoleate)IBA
06/2004 - 03/2004
2Arachidonic Acid (Vitamin F)IBA
06/2004 - 03/2004
2Estrogen Receptor Modulators (Antiestrogen)IBA
01/2003 - 11/2002
1NucleolinIBA
01/2022
1venetoclaxIBA
10/2021
1navitoclaxIBA
10/2021
1PalmitatesIBA
10/2021
1S63845IBA
10/2021
1AgarIBA
03/2021
1ProteomeIBA
03/2021
1ProlactinIBA
12/2020

Therapy/Procedure

14Therapeutics
10/2021 - 01/2003
7Drug Therapy (Chemotherapy)
05/2011 - 05/2003
3Mediterranean Diet
12/2006 - 10/2006
1Oral Administration
10/2021